Moderna will send far fewer COVID-19 shots to Canada this month than originally planned as the company grapples with production issues at its facilities in Europe.
But its main competitor, Pfizer — which also produces a highly effective mRNA vaccine against the novel coronavirus — has said it will send millions more doses to Canada in May, June and beyond, a commitment that will more than cover the shortfall from Moderna.
Massachusetts-based Moderna was poised to send 1.2 million more doses to Canada this month, but that shipment has been cut back to just 650,000 shots.
